Title : New Antithrombotic Drugs in Acute Coronary Syndrome.

Pub. Date : 2020 Jun 30

PMID : 32629976






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In recent years, much progress has been made in the field of antithrombotic drugs in acute coronary syndrome (ACS) treatment, as reflected by the introduction of the more potent P2Y12-inhibitors prasugrel and ticagrelor, and novel forms of concomitant anticoagulation, such as fondaparinux and bivalirudin. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens